| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9328358 | Gynecologic Oncology | 2005 | 8 Pages |
Abstract
A second curettage cured 9.4% of patients with PTD in this historical cohort and reduces the number of courses of chemotherapy. A second curettage seems to benefit only a limited number of patients with PTD. A randomized controlled prospective trial is needed to confirm this observation.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Nienke E. van Trommel, Leon F.A.G. Massuger, René H.M. Verheijen, Fred C.G.J. Sweep, Chris M.G. Thomas,